The final data set from NeoDynamics’ PULSE study shows favorable safety and efficacy profile of NeoNavia for ultra-sound guided biopsies in the axillary lymph nodes. The data are being presented. | May 5, 2023
above.
Item 12 - Resolution on authorization
The board of directors proposes that the annual general meeting authorizes the board of directors, for the time until the next annual general meeting,. | April 24, 2023
NeoDynamics AB held an Extraordinary General Meeting today on 3 April 2023. The Extraordinary General Meeting resolved in accordance with the following
Authorization
The boards proposal to. | April 3, 2023